The molecular basis of genetic dominance.
Open Access
- 1 February 1994
- journal article
- review article
- Published by BMJ in Journal of Medical Genetics
- Vol. 31 (2), 89-98
- https://doi.org/10.1136/jmg.31.2.89
Abstract
Studies of mutagenesis in many organisms indicate that the majority (over 90%) of mutations are recessive to wild type. If recessiveness represents the 'default' state, what are the distinguishing features that make a minority of mutations give rise to dominant or semidominant characters? This review draws on the rapid expansion in knowledge of molecular and cellular biology to classify the molecular mechanisms of dominant mutation. The categories discussed include (1) reduced gene dosage, expression, or protein activity (haploinsufficiency); (2) increased gene dosage; (3) ectopic or temporally altered mRNA expression; (4) increased or constitutive protein activity; (5) dominant negative effects; (6) altered structural proteins; (7) toxic protein alterations; and (8) new protein functions. This provides a framework for understanding the basis of dominant genetic phenomena in humans and other organisms.Keywords
This publication has 119 references indexed in Scilit:
- APC mutations occur early during colorectal tumorigenesisNature, 1992
- Retinal genetics: a nullifying effect for rhodopsinNature Genetics, 1992
- The origin of pattern and polarity in the Drosophila embryoCell, 1992
- Absence of expression of the FMR-1 gene in fragile X syndromeCell, 1991
- When to be diploidNature, 1991
- Consider the coiled coilNature, 1991
- The GTPase superfamily: conserved structure and molecular mechanismNature, 1991
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 1988
- Mutation of Antitrypsin to AntithrombinNew England Journal of Medicine, 1983
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971